A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Trial Profile

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Jul 2018

At a glance

  • Drugs Insulin lispro/pramlintide (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus First in man; Pharmacokinetics
  • Sponsors Adocia
  • Most Recent Events

    • 18 Jul 2018 According to an Adocia media release, top-line results from the trial are expected in Q3 2018.
    • 19 Apr 2018 Status changed from planning to not yet recruiting.
    • 16 Apr 2018 According to an Adocia media release, Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top